Chiayi Chang Gung Memorial Hospital, Pu-Tz, Chia-Yi, Taiwan.
Medicine (Baltimore). 2022 Jun 24;101(25):e29543. doi: 10.1097/MD.0000000000029543.
A significant number of patients suffers from refractory trigeminal neuralgia (TN) after receiving microvascular decompression (MVD) or other neuro-destructive procedure such as gamma knife radiosurgery (GKRS). This study aims to demonstrate a remediable, reproducible approach to treating refractory pain effectively by percutaneous radiofrequency trigeminal rhizotomy (RF-TR).A total of 392 patients with TN were treated by RF-TR during the past 10 years. Among these patients, 48 cases who had received either MVD, GKRS alone, or a combination of both were assigned to group A. Those who had not received any form of treatment (125 patients) or failed to respond medically (130 patients) were assigned as the control group (group B). All the RF-TR were performed by a single surgeon with the aid of intraoperative computed tomography (iCT)-based neuronavigation with magnetic resonance (MR) image fusion. The outcome measure was the numerical rating scale (NRS) expressed subjectively by patients. The paired Student t test and the analysis of covariance (ANCOVA) were used for statistical analysis.In group A, 21 of 24 patients (88%) had significant improvement (NRS change ≥5) in facial pain after RF-TR. The average NRS score was 9.75 ± 0.53 before the procedure and 1.92 ± 3.35 post-treatment (significant NRS decrease [P = .000]). On the other hand, in group B, 226 of 255 patients (89%) also had dramatic amelioration of facial pain after RF-TR. The average NRS score was 9.46 ± 0.69 before the procedure and 1.62 ± 2.85 post-treatment (7.84 ± 2.82 in NRS decrease [P = .008]). By using a univariate ANCOVA, no statistical significance was found in NRS score improvement between the two groups.Repeated MVD and GKRS for refractory TN may be less desirable due to a greater risk of mortality (up to 0.8%) and morbidity (4% of serious complications). Conversely, RF-TR administration with the novel navigation technique by using iCT and MR image fusion is free from any remarkable and irreversible morbidities. In this study, RF-TR not only provided an alternative and effective strategy if TN recurred but also resulted in the same NRS score improvement regardless of the status of prior treatment.
相当数量的患者在接受微血管减压术(MVD)或伽玛刀放射外科手术(GKRS)等神经破坏性治疗后出现难治性三叉神经痛(TN)。本研究旨在通过经皮射频三叉神经根切断术(RF-TR),展示一种可治疗、可重复的有效治疗难治性疼痛的方法。
在过去的 10 年中,共有 392 例 TN 患者接受了 RF-TR 治疗。其中,48 例患者接受了 MVD、GKRS 单独治疗或两者联合治疗,被分配到 A 组。125 例未接受任何形式治疗或药物治疗无效的患者(130 例)被分配为对照组(B 组)。所有的 RF-TR 均由同一位外科医生在术中 CT(iCT)引导下的磁共振(MR)图像融合的辅助下进行。评估指标是患者主观表达的数字评分量表(NRS)。采用配对学生 t 检验和协方差分析(ANCOVA)进行统计学分析。
在 A 组中,24 例患者中有 21 例(88%)在 RF-TR 后面部疼痛明显改善(NRS 变化≥5)。治疗前平均 NRS 评分为 9.75±0.53,治疗后为 1.92±3.35(NRS 显著下降[P=0.000])。另一方面,在 B 组中,255 例患者中有 226 例(89%)在 RF-TR 后面部疼痛也得到了显著缓解。治疗前平均 NRS 评分为 9.46±0.69,治疗后为 1.62±2.85(NRS 下降 7.84±2.82[P=0.008])。采用单因素协方差分析,两组间 NRS 评分改善无统计学意义。
对于难治性 TN,重复进行 MVD 和 GKRS 治疗可能不太理想,因为死亡率(高达 0.8%)和发病率(严重并发症 4%)较高。相反,使用 iCT 和 MR 图像融合的新型导航技术进行 RF-TR 治疗,没有任何明显和不可逆转的病态。在这项研究中,RF-TR 不仅提供了一种替代的有效策略,如果 TN 复发,还能获得相同的 NRS 评分改善,而与先前治疗的状况无关。